Updated bone mineral density status in Saudi patients with inflammatory bowel disease

Table 1 Comparison of demographic characteristics and patients’ clinical profile in the Crohn’s disease and ulcerative colitis groups

Parameters	CD (62 pts)	UC (28 pts)	P value
Age (yr)	29.23 ± 7.58	33.22 ± 10.53	NS
Sex (males), n (%)	32 (52)	17 (61)	NS
Smoking (%)	10	29	NS
BMI (kg/m2)	22.2 ± 3.52	25.646 ± 2.87	< 0.05
Abdominal pain (%)	83	17	NS
Bloody diarrhea (%)	67	96	NS
Bleeding per rectum (%)	3	4	NS
Malabsorption syndrome (%)	19	0	< 0.05
Perianal disease (%)	59	4	NS
Weight loss (%)	11	0	< 0.05
Extraintestinal manifestations (%)	21	7	NS
Comorbidities (%)	8	18	NS
Previous IBD-related admission (n)	2.16 ± 1.48	0.7 ± 0.44	< 0.05
Previous related surgeries (%)	33	4	NS
Family history (%)	15	4	NS
Steroid therapy (%)	79	71	NS
Azathioprine (%)	82	37	NS
Mesalamine (%)	10	81	< 0.05
Anti-TNF therapy (%)	65	29	NS

CD: Crohn’s disease; UC: Ulcerative colitis; pts: Patients; BMI: Body mass index; IBD: Inflammatory bowel disease; TNF: Tumor necrosis factor; NS: Not significant.